MED

Medifast, Inc. · NYSE · Consumer Cyclical · USD · 10-K for 2025, filed 2026-02-17

Figures on this page computed 2026-11-08 12:40 UTC

Last close

13.15USD

Market data, 2026-11-04

Except where said otherwise: 10-K for 2025, filed 2026-02-17

n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2025
Accession
0001628280-26-008656
Reported in
USD
- computed
- 10-K for 2025, filed 2026-02-17
The filing itself
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0001628280-26-008656
Reported in
USD
- 10-K for 2025, filed 2026-02-17
- 10-K for 2025, filed 2026-02-17
- 10-K for 2025, filed 2026-02-17
- 10-Q for 2025, filed 2026-10-26
- 10-K for 2025, filed 2026-02-17
- 10-Q for 2025, filed 2026-10-26
The filing itself
-4.8%Net margin
Net Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001628280-26-008656
Reported in
USD
- 10-K for 2025, filed 2026-02-17
- 10-K for 2025, filed 2026-02-17
The filing itself
0.3%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001628280-26-008656
Reported in
USD
- 10-K for 2025, filed 2026-02-17
- 10-K for 2025, filed 2026-02-17
The filing itself
0.05Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2025
Accession
0001628280-26-008656
Reported in
USD
- 10-K for 2025, filed 2026-02-17
- 10-Q for 2025, filed 2026-10-26
The filing itself
0.1%Dividend yield
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Growth is the furthest below its sector's middle: 0.04 against 0.44 on the market's range.

All from 100

lens 2 of 9

Sales

141

2016-12-31 to 2025-12-31100 at the start141

Sales: 100.00 on 2016-12-31 to 140.52 on 2025-12-31, up 41%.

Profit

-105

2016-12-31 to 2025-12-31100 at the start-105

Profit: 100.00 on 2016-12-31 to -104.69 on 2025-12-31, down 205%.

Shares in issue

91.9

2016-12-31 to 2025-12-31100 at the start91.9

Shares in issue: 100.00 on 2016-12-31 to 91.91 on 2025-12-31, down 8%.

Sales is at 140, Profit is at -105, Shares in issue is at 92, against 100 in 2016.

Sales is at 140, Profit is at -105, Shares in issue is at 92, against 100 in 2016.

Every figure in this lens

Except where said otherwise: 10-K for 2025, filed 2026-02-17

Sales, where the first year is 100141
Source
filed
Statement
income
Fiscal year
2025
Accession
0001628280-26-008656
Reported in
USD
The filing itself
Profit, where the first year is 100-105
Source
filed
Statement
income
Fiscal year
2025
Accession
0001628280-26-008656
Reported in
USD
The filing itself
Shares in issue, where the first year is 10092
Source
filed
Statement
income
Fiscal year
2025
Accession
0001628280-26-008656
Reported in
USD
The filing itself